Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 18/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CYP51A1 | Q16850 | 3/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.54 |
| ▸ | FYN | P06241 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.54 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.54 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9662728 | 0.87 | CYP3A4 (0.58) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL10673227 | 0.87 | CYP3A4 (0.58) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL9663596 | 0.83 | CYP3A4 (0.56) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL10674072 | 0.83 | CYP3A4 (0.56) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL2615012 | 0.83 | CYP3A4 (0.76) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL10765664 | 0.81 | CYP3A4 (0.54) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL9664951 | 0.81 | CYP3A4 (0.72) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL17739438 | 0.81 | CYP3A4 (0.72) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL9662019 | 0.80 | CYP3A4 (0.62) | CYP3A4LMNACYP51A1HSP90AA1FYN | |
| SCHEMBL10469043 | 0.80 | CYP3A4 (0.62) | CYP3A4LMNACYP51A1HSP90AA1FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210299044-A1 | SYSTEMS AND METHODS FOR DELIVERY OF DRUGS AND OTHER SUBSTANCES COMPRISING DEEP EUTECTIC SOLVENTS | Novilla Pharmaceuticals, Inc. (US) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299044-A1 | SYSTEMS AND METHODS FOR DELIVERY OF DRUGS AND OTHER SUBSTANCES COMPRISING DEEP EUTECTIC SOLVENTS | PTGES, PTGER3, PTGES3 | CYP3A4 845/4885LMNA 1465/4885CYP51A1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.